David K Meyerholz Selected Research

asapiprant

1/2022	Eicosanoid signalling blockade protects middle-aged mice from severe COVID-19.
4/2021	Eicosanoid signaling as a therapeutic target in middle-aged mice with severe COVID-19.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David K Meyerholz Research Topics

Disease

46	Infections 01/2022 - 07/2004
26	Inflammation (Inflammations) 01/2022 - 10/2004
18	Cystic Fibrosis (Mucoviscidosis) 01/2022 - 10/2004
16	Neoplasms (Cancer) 01/2022 - 07/2007
11	COVID-19 01/2022 - 01/2020
9	Pneumonia (Pneumonitis) 01/2022 - 05/2004
9	Virus Diseases (Viral Diseases) 07/2021 - 05/2004
9	Lung Diseases (Lung Disease) 01/2021 - 06/2009
9	Respiratory Syncytial Virus Infections 01/2020 - 01/2006
5	Hypertension (High Blood Pressure) 01/2019 - 09/2015
5	Asthma (Bronchial Asthma) 10/2018 - 07/2013
5	Pancreatitis 01/2013 - 11/2007
4	Paramyxoviridae Infections (Parainfluenza) 07/2021 - 05/2004
4	Weight Loss (Weight Reduction) 01/2021 - 02/2015
3	Body Weight (Weight, Body) 01/2022 - 08/2007
3	Human Influenza (Influenza) 12/2021 - 07/2008
3	Severe Acute Respiratory Syndrome 02/2016 - 11/2009
3	Respiratory Tract Infections (Respiratory Tract Infection) 10/2015 - 11/2011
3	Meconium Ileus 06/2013 - 09/2008
3	Necrosis 10/2011 - 05/2005
3	Burns 08/2010 - 02/2009
2	B-Cell Lymphoma (Lymphoma, B Cell) 10/2022 - 04/2016
2	Fibrosis (Cirrhosis) 10/2022 - 11/2009
2	Obesity 01/2022 - 01/2020
2	Neurofibrosarcoma (MPNST) 01/2022 - 01/2020
2	Insulin Resistance 01/2022 - 01/2020
2	Primitive Neuroectodermal Tumors (PNET) 06/2021 - 01/2019
2	Neurofibromatosis 1 (Neurofibromatosis Type I) 01/2020 - 11/2019
2	Pain (Aches) 11/2019 - 01/2018
2	Inborn Genetic Diseases (Disease, Hereditary) 11/2019 - 10/2018
2	Cardiomegaly (Heart Hypertrophy) 01/2019 - 09/2015
2	Persistent Infection 01/2018 - 09/2012
2	Coronavirus Infections 01/2016 - 12/2015
2	Prostatic Neoplasms (Prostate Cancer) 11/2014 - 09/2009
2	Neoplasm Metastasis (Metastasis) 11/2014 - 07/2011

Drug/Important Bio-Agent (IBA)

23	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2004
16	CytokinesIBA 01/2022 - 10/2005
12	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 01/2022 - 08/2008
8	VaccinesIBA 12/2021 - 03/2015
7	Antiviral Agents (Antivirals)IBA 01/2021 - 01/2007
7	AntigensIBA 01/2018 - 11/2004
6	Pharmaceutical PreparationsIBA 01/2022 - 11/2014
6	Surface-Active Agents (Surfactants)IBA 03/2016 - 05/2004
5	Messenger RNA (mRNA)IBA 01/2022 - 05/2004
5	MucinsIBA 01/2022 - 05/2011
5	RNA (Ribonucleic Acid)IBA 10/2020 - 07/2007
5	AnionsIBA 09/2017 - 03/2011
5	Ethanol (Ethyl Alcohol)IBA 11/2011 - 08/2007
5	beta-DefensinsIBA 01/2006 - 05/2004
4	Biological ProductsIBA 01/2022 - 07/2011
4	Glycoproteins (Glycoprotein)IBA 01/2022 - 05/2011
4	InterferonsIBA 01/2021 - 02/2015
4	Angiotensin-Converting Enzyme 2IBA 10/2020 - 01/2007
3	IronIBA 01/2022 - 11/2009
3	Biomarkers (Surrogate Marker)IBA 06/2021 - 04/2020
3	Phosphotransferases (Kinase)IBA 01/2020 - 11/2008
3	AntibodiesIBA 01/2020 - 05/2011
3	ErbB Receptors (EGF Receptor)IBA 01/2020 - 06/2013
3	Interleukin-10 (Interleukin 10)IBA 01/2019 - 01/2007
3	Angiotensin IIIBA 01/2019 - 09/2015
3	Respiratory Syncytial Virus VaccinesIBA 03/2015 - 02/2008
3	ChemokinesIBA 02/2015 - 01/2007
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2011 - 01/2007
3	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 01/2008 - 05/2004
2	Phospholipases (Phospholipase)IBA 01/2022 - 10/2015
2	asapiprantIBA 01/2022 - 04/2021
2	EicosanoidsIBA 01/2022 - 04/2021
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2015
2	Prostaglandin D2IBA 01/2022 - 01/2017
2	OxidesIBA 01/2022 - 04/2020
2	Amyloid (Amyloid Fibrils)IBA 01/2022 - 05/2005
2	Insulin (Novolin)FDA Link 01/2022 - 08/2010
2	COVID-19 VaccinesIBA 07/2021 - 04/2021
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 02/2015
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 03/2014
2	InterleukinsIBA 01/2021 - 01/2007
2	Protease Inhibitors (Protease Inhibitor)IBA 01/2021 - 01/2021
2	Phenobarbital (Luminal)FDA Link 11/2020 - 12/2013
2	LigandsIBA 01/2020 - 01/2019
2	Neurofibromin 1 (Neurofibromin)IBA 01/2020 - 11/2019
2	Neutralizing AntibodiesIBA 01/2020 - 10/2014
2	Nicotine FDA Link 01/2019 - 10/2016
2	Cholinergic Agents (Cholinergics)IBA 01/2019 - 10/2016
2	Interleukin-8 (Interleukin 8)IBA 01/2018 - 07/2004
2	CollagenIBA 01/2018 - 02/2009
2	CalciumIBA 01/2018 - 04/2016
2	Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA 10/2017 - 07/2013
2	ProstaglandinsIBA 01/2017 - 02/2010
2	Interferon Type IIBA 02/2016 - 09/2009
2	Formaldehyde (Formol)FDA Link 03/2015 - 02/2008
2	Nucleotide AptamersIBA 11/2014 - 09/2009
2	ArginaseIBA 05/2014 - 12/2013
2	Chloride Channels (Chloride Channel)IBA 05/2014 - 03/2014
2	AllergensIBA 07/2013 - 08/2010
2	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2013 - 11/2009

Therapy/Procedure

18	Therapeutics 06/2021 - 10/2004
5	Ligation 01/2013 - 11/2007
3	Lasers (Laser) 11/2019 - 01/2006
2	Lung Transplantation 10/2022 - 01/2018
2	Injections 01/2018 - 07/2011